Glanbia Nutritionals is the exclusive distributor for pTeroPure brand pterostilbene in North America.
Glanbia Nutritionals (Evanston, IL) is now the exclusive distributor for pTeroPure brand pterostilbene in North America.
Pterostilbene is an antioxidant derived from berries. Pharmalogically similar to resveratrol, pterostilbene is linked to potential heart health, cognitive, and anti-aging benefits. The nature-identical pTeroPure was developed and patented by ChromaDex Corp. (Irvine, CA).
"We are looking forward to the national expansion of pTeroPure and its adoption into numerous consumer products," said ChromaDex founder and CEO Frank Jaksch. "Glanbia, together with its superb sales, marketing, and R&D teams, is an ideal partner for ChromaDex. With our recently announced pTeroPure clinical safety results and the forthcoming human efficacy data, Glanbia should be well positioned to bring our exciting, novel, patented, and proven ingredient to the food and beverage, dietary supplement, and animal health markets."
Chromadex reports that its ingredient is currently being assessed in a human clinical trial for potential blood pressure, cholesterol, and oxidative stress support.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.